Literature DB >> 11857319

Episodic (breakthrough) pain: consensus conference of an expert working group of the European Association for Palliative Care.

Sebastiano Mercadante1, Lukas Radbruch, Augusto Caraceni, Nathan Cherny, Stein Kaasa, Friedemann Nauck, Carla Ripamonti, Franco De Conno.   

Abstract

BACKGROUND: Breakthrough pain is transitory exacerbation of pain that occurs in addition to otherwise stable persistent pain. The wide differences in estimation of incidence reported in literature are probably because of different settings and meanings attributed to the definition of breakthrough pain.
METHODS: A panel of experts met to establish the actual knowledge on breakthrough pain, according to the evidence in literature and experience. They agreed that episodic or transient pain could be a more simple and adequate term in most languages, including English, French, Italian, and Spanish.
RESULTS: A specific assessment and precise pain characterization are essential to plan the most appropriate treatments. Despite the relevance of this temporal pain pattern for the influence on the outcome and quality of life, few controlled studies have been performed to give evidence of a specific approach. Several experiences have reported the possible efficacy of different drugs, route of administration, and modalities of administration in different circumstances.
CONCLUSIONS: Prospective studies with previous treatments using similar terminologies are necessary to find the most convenient therapeutic intervention, according to the temporal pattern characteristics and the pain mechanism involved. Copyright 2002 American Cancer Society. DOI 10.1002/cncr.10249

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11857319     DOI: 10.1002/cncr.10249

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  69 in total

1.  [To sedate or not to sedate-that is the question here : Palliative sedation between standard care and flexibility].

Authors:  L Radbruch; F Nauck
Journal:  Schmerz       Date:  2010-08       Impact factor: 1.107

Review 2.  Substance abuse in cancer pain.

Authors:  Tatiana D Starr; Lauren J Rogak; Steven D Passik
Journal:  Curr Pain Headache Rep       Date:  2010-08

3.  Diagnosis and management of breakthrough cancer pain: Have all the questions been resolved? A Delphi-based consensus assessment (DOIRON).

Authors:  J Porta-Sales; C Pérez; Y Escobar; V Martínez
Journal:  Clin Transl Oncol       Date:  2015-12-22       Impact factor: 3.405

4.  Long-term tolerability, efficacy and acceptability of fentanyl pectin nasal spray for breakthrough cancer pain.

Authors:  Lukas Radbruch; Luis M Torres; John E Ellershaw; Antonio Gatti; Guillermo Luis Lerzo; Julia Revnic; Donald Taylor
Journal:  Support Care Cancer       Date:  2011-03-22       Impact factor: 3.603

5.  Breakthrough pain: a qualitative study involving patients with advanced cancer.

Authors:  Katherine Webber; Andrew N Davies; Martin R Cowie
Journal:  Support Care Cancer       Date:  2010-12-22       Impact factor: 3.603

Review 6.  Strong opioids in pediatric palliative medicine.

Authors:  Richard D W Hain; Angela Miser; Mary Devins; W Hamish B Wallace
Journal:  Paediatr Drugs       Date:  2005       Impact factor: 3.022

Review 7.  Difficult pain.

Authors:  Lesley Colvin; Karen Forbes; Marie Fallon
Journal:  BMJ       Date:  2006-05-06

8.  Intermittent cancer pain: clinical importance and an updated cancer pain classification.

Authors:  Wael Lasheen; Declan Walsh; Nabeel Sarhill; Mellar Davis
Journal:  Am J Hosp Palliat Care       Date:  2009-12-14       Impact factor: 2.500

Review 9.  Management of breakthrough pain in patients with cancer.

Authors:  Leeroy William; Rod Macleod
Journal:  Drugs       Date:  2008       Impact factor: 9.546

Review 10.  [Cancer pain therapy].

Authors:  F Nauck
Journal:  Urologe A       Date:  2009-10       Impact factor: 0.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.